Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study

NCT01114269 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT01114269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01114269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
July 31, 2007
Completion date
November 30, 2026
Enrollment
5,764 (actual)
Sites
90

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, left ventricular dysfunction, sudden cardiac death